Bimi International Medical Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Bimi International Medical Inc (BIMI) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Bimi International Medical Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 6M vs 677,675M combined for its competitors (0.0% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+72.6% annualized vs trailing 12 months), vs decelerating (-5.3%) for its tracked peer group.
- Growth: Bimi International Medical Inc generated -48.9% revenue growth year over year in Q3 2023, vs 11.4% for its competitors combined.
- Profitability: Its -128.8% net margin compares with -4.9% for the peer group.
- Peer revenue share: Bimi International Medical Inc accounted for 0.0% of combined revenue among its tracked peer group, up from 0.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
BIMI Sales vs. its Competitors, Q3 2023
Bimi International Medical Inc reported revenue contraction of 48.85 % year on year in Q3 2023, below its competitors' combined revenue growth of 11.36 %.
With a net margin of -128.84 %, Bimi International Medical Inc reported lower profitability than its competitors (-4.85 %).
Bimi International Medical Inc generated 0.00 % of the combined sales of its peer group, up from 0.00 % a year earlier.
API endpoints for this dataset
Bimi International Medical Inc vs. its Competitors, Q3 2023
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in Bimi International Medical Inc reports; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Bimi International Medical Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Bimi International Medical Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Bimi International Medical Inc's competitor groups requires a Commercial License.
For context: the Pharmacy Services & Retail Drugstore industry grew revenue 6.7% year over year, combined, vs -48.9% for Bimi International Medical Inc. Bimi International Medical Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.
Bimi International Medical Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Bimi International Medical Inc | - | No | No | No |
| Competitors combined (45) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
BIMI Stock Performance relative to its Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Ampco pittsburgh Corp | 282.9% | Outperformed |
| 2 | Idex Corp | 282.9% | Outperformed |
| 3 | Air Products And Chemicals Inc | 282.9% | Outperformed |
| 4 | Huntsman Corporation | 282.9% | Outperformed |
| 5 | Watts Water Technologies Inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Bimi International Medical Inc's best-performing competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Publicly Traded Peers of Bimi International Medical Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
 Bimi International Medical Inc |
0.00 | 5.85 |
 Danaher Corporation |
162,740.70 | 25,608.00 |
 Eaton Corporation Plc |
133,134.11 | 31,984.00 |
 Parker hannifin Corporation |
117,568.90 | 21,499.00 |
 3m Company |
96,759.39 | 25,247.00 |
 Honeywell International Inc |
70,239.96 | 30,716.00 |
| SUBTOTAL | 912,970.38 | 679,211.77 |
Sign in to see all competitors of Bimi International Medical Inc .
Sources: see Methodology: Peer & Competitor Identification, Sourcing.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Bimi International Medical Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Bimi International Medical Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Danaher Corporation | Diagnostics 43.97 % |
| Eaton Corporation Plc | Electrical Americas 46.63 % |
| Parker hannifin Corporation | Diversified Industrial 66.93 % |
| 3m Company | Safety and Industrial 48.33 % |
| Honeywell International Inc | Building Automation 40.45 % |
Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Sign in to see all peers for Bimi International Medical Inc .
Bimi International Medical Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Bimi International Medical Inc | 0 | - | - |
| Danaher Corporation | 162,741 | 426,800 | 72,183 |
| Eaton Corporation Plc | 133,134 | 328,705 | 40,102 |
| Parker hannifin Corporation | 117,569 | 359,215 | 60,969 |
| 3m Company | 96,759 | 417,306 | 58,579 |
| Honeywell International Inc | 70,240 | 304,119 | 69,525 |
| PEERS TOTAL | 912,970 | 567,384 | 98,787 |
Sign in to see all peers for Bimi International Medical Inc .
Bimi International Medical Inc's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent report. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Danaher Corporation | North America 41.81 % |
| Parker hannifin Corporation | North America 67.21 % |
| 3m Company | United States 46.28 % |
| Dover Corp | United States 56.96 % |
| Genuine Parts Co | United States 64.75 % |
Source: revenue geography as reported in each company's reports (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Sign in to see all peers for Bimi International Medical Inc .
Bimi International Medical Inc's Position in Industry Market Structure
Market-capitalization share and concentration across all 13 companies in Bimi International Medical Inc's industry classification, broader than the peer set above. Market cap in millions of $.Bimi International Medical Inc ranks #0 of 13 companies by market capitalization in its industry, holding 0.00 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 2,650, indicating a highly concentrated market structure (see Methodology: Market Structure & Concentration).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Mckesson Corporation | 126,452 | 34.34 % |
| 2 | Cvs Health Corporation | 107,915 | 29.30 % |
| 3 | Cencora Inc | 64,692 | 17.57 % |
| 4 | Cardinal Health Inc | 64,126 | 17.41 % |
| 5 | Guardian Pharmacy Services Inc | 1,234 | 5.2% |
| 6 | Herbalife Ltd | 1,234 | 5.2% |
| 7 | 111 Inc | 1,234 | 5.2% |
| 8 | Nu Skin Enterprises Inc | 1,234 | 5.2% |
| 9 | Petmed Express Inc | 1,234 | 5.2% |
| 10 | Zerostack Corp | 1,234 | 5.2% |
| 0 | Bimi International Medical Inc | 0 | 0.00 % |
Market cap and industry share for the rest of Bimi International Medical Inc's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-11-05.
Bimi International Medical Inc's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Pharmacy Services & Retail Drugstore industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (34 companies). See the full Pharmacy Services & Retail Drugstore industry profitability benchmarks.| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 88.61 % | 23.46 % (avg) | +65.2 pp |
| Operating Margin | - | industry median | - |
| EBITDA Margin | - | -1.08 % (avg) | - |
| Capital Intensity (Capex / Revenue) | 10.33 % | 2.47 % (avg) | +7.9 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Bimi International Medical Inc's Valuation vs Competitive Position
Valuation multiples vs the Pharmacy Services & Retail Drugstore industry average (34 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Pharmacy Services & Retail Drugstore industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 24.4x | - |
| EV / EBITDA | - | 12.5x | - |
| P/B | 1.7x | 3.5x | -1.8x |
| Return on Equity | -263.69 % | industry aggregate | -273.34 % |
| Return on Invested Capital | -58.88 % | 10.39 % (avg) | -69.27 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Bimi International Medical Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in company reports.| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue Growth | -32.72 % | -10.03 % | 40.83 % | -23.11 % | -97.59 % | 500.00 % | 110.62 % | -81.37 % |
| Operating Margin | -9.54 % | -24.50 % | -14.05 % | -241.41 % | -1,084.38 % | -33.25 % | -35.31 % | - |
| Return on Invested Capital | -1.53 % | -3.70 % | -2.96 % | -49.97 % | -5.55 % | -15.32 % | -17.35 % | -75.89 % |
| P/E | - | - | - | - | - | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Bimi International Medical Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | Low | Industry HHI of 2,650 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | High (capital intensive) | Capital intensity (capex / revenue) of 10.33 % vs industry average 2.47 % (see Profitability & Cost Structure above) |
Note: see Methodology: Porter's Five Forces. Supplier power and buyer power are covered on Bimi International Medical Inc's dedicated Suppliers and Customers pages, not here.
Bimi International Medical Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Latest-quarter revenue run-rate is accelerating (+72.6% annualized vs trailing 12 months).
Weaknesses
- Return on equity 273.3 points below the industry aggregate.
Opportunities
No rule matched.
Threats
- Tracked peer group's revenue run-rate is broadly decelerating (-5.3% annualized).
- High capital intensity requires continuous reinvestment just to keep pace with the industry.
Methodology: see Methodology: SWOT Analysis.
Bimi International Medical Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Bimi International Medical Inc | 0.08 | 1.15 | 0.18 |
| Danaher Corporation | - | 1.75 | 0.45 |
| Eaton Corporation Plc | 0.05 | 1.24 | 0.89 |
| Parker hannifin Corporation | 0.08 | 1.16 | 0.65 |
| 3m Company | - | 1.47 | 3.62 |
| Honeywell International Inc | 0.47 | 1.24 | 1.69 |
Sign in to see all peers for Bimi International Medical Inc .
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Bimi International Medical Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Bimi International Medical Inc | Q3 2023 | -48.8 % | - |
| Danaher Corporation | Q3 2026 | +8.3 % | +36.0 % |
| Eaton Corporation Plc | Q3 2026 | +28.0 % | +6.7 % |
| Parker hannifin Corporation | Q2 2026 | +9.8 % | +18.2 % |
| 3m Company | Q3 2026 | +1.0 % | +63.3 % |
| Honeywell International Inc | Q3 2026 | -52.0 % | -64.3 % |
| PEERS TOTAL | +6.1 % | +49.0 % |
Sign in to see all peers for Bimi International Medical Inc .
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Bimi International Medical Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Bimi International Medical Inc | Q3 2023 | -43.1 % | - |
| Danaher Corporation | Q3 2026 | +7.4 % | -12.7 % |
| Eaton Corporation Plc | Q3 2026 | +35.5 % | +54.5 % |
| Parker hannifin Corporation | Q2 2026 | +6.8 % | +32.2 % |
| 3m Company | Q3 2026 | +0.2 % | +17.4 % |
| Honeywell International Inc | Q3 2026 | -5.7 % | - |
Sign in to see all peers for Bimi International Medical Inc .
Bimi International Medical Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Bimi International Medical Inc | - | - | - |
| Danaher Corporation | 4.91% | 5.57% | 8.18% |
| Eaton Corporation Plc | 7.43% | 9.80% | 19.38% |
| Parker hannifin Corporation | 11.99% | 15.10% | 25.38% |
| 3m Company | 9.60% | 13.24% | 93.07% |
| Honeywell International Inc | 10.10% | 15.11% | 39.45% |
Sign in to see all peers for Bimi International Medical Inc .
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Bimi International Medical Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Bimi International Medical Inc | - | 0.00 |
| Danaher Corporation | 37.75 | 6.36 |
| Eaton Corporation Plc | 34.21 | 4.16 |
| Parker hannifin Corporation | 32.24 | 5.47 |
| 3m Company | 27.59 | 3.83 |
| Honeywell International Inc | 10.46 | 2.29 |
| PEERS AVERAGE | 7.72 | 1.34 |
Sign in to see all peers for Bimi International Medical Inc .
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.